全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2019 

Engineering a Brighter Future: The Evolving Role of the Pharmacist in the Era of the HeartMate 3

DOI: 10.1177/1060028018813371

Keywords: anticoagulation,HeartMate 3,hemocompatibility,left-ventricular assist device

Full-Text   Cite this paper   Add to My Lib

Abstract:

Continuous-flow left-ventricular assist devices (CF-LVADs) are an option for patients with end-stage heart failure requiring durable mechanical circulatory support. Two of the older-generation CF-LVADs have been associated with multiple device-related complications, including bleeding and thrombosis. The newest generation CF-LVAD, the HeartMate 3, was engineered specifically to prevent device-related thrombosis. As more data enhance our understanding of the burden of bleeding and thrombotic adverse events, patients with durable mechanical circulatory support may require less-aggressive antithrombotic therapy

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133